Member Info for LTbeliever

I guess that's a BUY?
Maybe an RNS tomorrow about STC, after all?? :)

RB40,
I am not saying we have (yet) a problem, I am saying that we need to see some numbers/results soon, to see how well all these various projects are doing and that cash burn is within budget. Hopefully, all the worries will be put to rest by July, if we get meaningful numbers/RNSs by then.
It seems that GJB is more careful now with his Twits and tries to keep the deadlines he sets.
If we get an update (RNS??) tomorrow on STC's progress, that would be a good start.
GLA

The next 2-3 months will be critical IMO. We are expecting news on Mtox PD mass production, how STC's launch is going, Mtox BT update promised in "H1", plus any update on China deal; April will see the end of more trials too.
In the meantime, cash is being eaten up so we need to see what, and how soon, cash inflows will commence.
GJB is quite good in self-promotion, question is, will he successfully cope with all these projects whilst not letting cash burn grow out of control?

No apologies needed, Chesh.
We will know in a few days what these "news" is all about, I am optimistic that we will get some numbers - STC was launched back in November, so who knows? A deal is not completely out of question.
Plus, we have 4 (or 5?) vans out with Mobile Water Services, I guess these vans are not roaming the English countryside for fun but probably on behalf of a client (or clients) paying for the service?

Chesh,
The context used was expected news in either a marketing guise Vs an RNS (price sensitive).
Of course marketing is important and a lot of work is definitely being done (and eating cash), but as you see, the SP does not reflect this work (as yet)- if an RNS is announced re all the STC work/progress achieved, especially in the USA, then this should start reflecting on the SP soon. IMO

Well, GJB twitted last Friday that there would be news "in 1 week" about all the STC conferences that have taken place over the past few weeks.
Whether the news will be more marketing spin or an RNS about eg collaborations/contracts, only GJB knows.
GLA

https://www.microsaic.com/careers/

Expansion drive - good? Or, just increasing overheads?

I think not a SELL as it's way too cheap BUT definitely news of about revenues are needed. Nothing on bioprocessing, nothing on China.
If no news, it will simply remain a cheap stock with little prospects (a value trap).
On the positive side, DVRG should issue an RNS by May-June re Mtox PD mass production, so that should also lift MSYS.IMO

I guess Gerry is not too unhappy about it, wearing his DVRG cap!
A bid will come at the time of DVRG's choosing I guess.

Whoever is worried about this, they can always average down :)

Lutra,
I started a list to kick off a thinking process, so pls free to chip in.
My list was meant for things that would cause us a capital loss, a hostile takeover would have to offer a healthy premium to succeed so it wouldn't be too bad for holders, although it 'd depend on timing and price offered.
Yes, I agree that DVRG's SP performance is affected by market sentiment, especially towards tech stocks; mostly because these are "JAM tomorrow" stocks, selling products to Consumers; the huge difference with DVRG is that we sell both B-C (SkinTrust) and B-B (utilities and governments) and thus have a) a lower risk profile b) a more captive market.
We need though a few more months and RNSs before the Market starts making this distinction and rerates DVRG accordingly - IMO.

RT,
I'd guess that Labskin is a slow burner, there for longer term returns; maybe some cross selling opportunities to the big pharma clients and lower but more steady, recurring income; I think the aim here is AI-generated data, which can then be monetised - but, longer term unfortunately while it's absorbing precious cash today.

RT40,
And as to why borrow if the Co has cash (eg 5-6 mln, as per my calculation), well, there needs to be a cushion of some sort for normal expenditures. I am sure the loan was not taken to pay salaries and rent.

RT40,
I accept what you are saying about loan sharks but is 12%pa nowadays (with a liquidity crunch) too much for an UNSECURED loan, to a profitless company?
Mortgage rates are 2-3%pa, Overdraft and card rates 20%+.
Even at 12%pa, the lender has to wait 7-8 years just to get their capital back, so there is still a big risk to their capital, right? And why the eagerness to have the right to get shares in lieu of cash? I say it's because they see the huge potential (and profitability just around the corner).
I agree that expenses are probably higher than they should be and that more focus would be in order; on the other hand, if you are aiming to create - from scratch - multiple new markets because you don't know which one will take off first, this is the "price" to pay (with all the associated risks).

Some but as their inability to produce a decent Covid vaccine shows, copying IP is not full proof.
It's not just the hardware but also consumables, reagents etc, with many players involved hence more difficult to just copy and hope it will work.

PC,
Would be good to see the Co keeping on schedule for Mtox BT and mass production of Mtox PD (H1 2022).

Exactly right - MW Monitoring Services on the go!
Hopefully, another Sky News report to follow soon :)

RB40, thanks for the reminder.
According to this, we are probably Breaking Even. "Strong unaudited H2 revenues of £6m (2020: £3.4m) delivered first profitable EBITDA half year, excluding exceptional items."
https://www.lse.co.uk/rns/DVRG/trading-update-6e46qfzlkiy2j2s.html

As per the Interims,
https://www.lse.co.uk/rns/DVRG/interim-results-lbzbdu1542g868e.html
at June end we had 8mln cash. "Administration costs increased to £4.211m", Revenues 3.3mln, Gross Margin was 52%. Net cash used in operating activities was 3.1 mln.
So, a back of the envelope calculation (H2 sales 6mln, Gross Profit say 3mln, gross cash eaten up in H2? I say 6mln due to expansion etc) indicates that at Y/E 2021, the Co had cash of 5 mln (8mln+3-6).
Now, for H1 2022, assuming 12mln Revenues, and a Gross margin of 60% (due to service fees etc) gives us Gross cash of 5mln (from 2021) + 7mln minus 6-7 mln cash outflow (due to the expansion), gives us 5-6 mln at June 2022, ignoring the loan cash. So, we are at least Breaking even IMO.
If loss making, why would the lender risk 24 mln of hard cash?
All above based on my own assumptions of course so DYOR.

Any investor wants to know the risk to their investment.
1. Risk of running out of cash - minimal, as 20 mln (at high cost though) is available for drawdown;
2. Risk of lack of sales; With almost 6mln in Q1 - JUST FROM MW - it seems that the 2022 target of 20mln+ Revenues is achievable; we also have the STC launch in the US soon, and Mobile Water Service Monitoring any day now; plus, consumables and service fees (recurring, ongoing) from the already installed base of equipment; no RNSs issued ofr these due to the small relative size;
3. Risk to supply chain; with UK and Ireland production, DVRG is one of the few companies not to be affected by high energy costs or RM issues;
4. Client base - no sales in UKR and RUS, selling mainly to Governments and Utilities in safer parts of the world;
5. Non delivery of products - YES, we have delays and maybe overpromising (especially with Mtox BT) but as Mtox PD shows, testing in real life environments can take much longer than anticipated.
Personally, I expect that by the end of the summer, with the H1 Interims release, any remaining worries will disappear about the financial side of things. The rest will be sorted out early summer. IMO
DYOR

Just a guess, as tomorrow is the end of Q1 2022! Sticking to what was promised, would actually be a first :)

https://www.lse.co.uk/rns/DVRG/compact-microtox174-pd-launch-scheduled-for-q1-2022-o3d6yhcgbv06rr6.html